Start Date
January 31, 2017
Primary Completion Date
May 31, 2018
Study Completion Date
May 31, 2018
Exciton
"Exsalt® Wound Dressings will be applied by the physician/nursing staff.~The test product, exsalt® Wound Dressings (0.4 mg Ag/cm2) will be applied after wound cleansing or debridement if required.~Dressings will be changed weekly, either at the out-patient facility or at home with provided dressings. At regular intervals throughout the study, as per the existing Diabetes Foot Care Clinical Care Pathway, wound assessment including size determination, Exsalt Wound Assessment Form, any adverse events will be reported, with tracing and/or photography included where available.~Maximum treatment course will be 28 days (end of study) or until wound closure."
Collaborators (2)
Alberta Innovates Health Solutions
OTHER
Exciton Technologies Inc.
INDUSTRY
University of Alberta
OTHER